Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

The following is a summary of “Patient journey and decision processes for anti-amyloid therapy in Alzheimer’s disease,” ...

Mayo Clinic researchers are studying why some Alzheimer's patients decline rapidly, aiming to find causes, biomarkers, and ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

Experts also warn the boarding issue will worsen as the number of people 65 and older in the U.S. with dementia grows in the ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Music therapy is proving to be a powerful adjunct treatment for a range of conditions, including Alzheimer’s disease, chronic ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Advocates will rally in Carson City, Nevada on Wednesday for greater support for dementia patients and their families. More ...

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease ...